Recombinant Tapirus indicus Alpha-crystallin A chain (CRYAA)

Shipped with Ice Packs
In Stock

Description

Overview of Alpha-Crystallin A Chain (CRYAA)

Alpha-crystallin A chain (CRYAA) is a member of the small heat shock protein (sHSP) family, functioning as a molecular chaperone to prevent protein aggregation under stress conditions. It plays a critical role in maintaining lens transparency in the eye and is implicated in cellular stress responses across tissues. Recombinant CRYAA refers to the protein produced via genetic engineering in heterologous expression systems (e.g., E. coli, yeast, or mammalian cells) for research or therapeutic applications .

Table 1: Recombinant CRYAA Variants Across Species

SpeciesHost SystemTagPurityApplicationsSource
HumanE. coliHis tag>95%ELISA, WB
MouseE. coliHis tag>90%Chaperone assays
Rana temporariaYeastHis tag>90%ELISA
DuckYeastHis tag>90%ELISA

Note: No recombinant Tapirus indicus CRYAA has been documented in the provided sources. Data above represent homologs.

Research on CRYAA in Non-Model Species

While recombinant CRYAA is well-studied in humans and model organisms, no peer-reviewed studies on Tapirus indicus (Malayan tapir) CRYAA were identified in the provided sources. Key insights from related species include:

  • Oxidation Effects: Human CRYAA forms intramolecular disulfides under oxidative stress, altering oligomer size and chaperone activity .

  • Mutation Impact: The E156K mutation in human CRYAA enhances chaperone activity by increasing β-sheet content .

  • Expression Systems: Yeast-derived CRYAA achieves >90% purity with post-translational modifications, while E. coli systems offer cost-effective production .

Implications for Tapirus indicus CRYAA

The Malayan tapir (Tapirus indicus) is an endangered species with limited genetic data. Although its MHC genes have been characterized , CRYAA remains unstudied. Key research gaps include:

  • Sequence Variation: Whether tapir CRYAA has unique residues affecting stability or chaperone function.

  • Stress Adaptation: Role in ocular biology or response to environmental stressors (e.g., UV exposure).

  • Conservation Needs: Low genetic diversity in tapirs may heighten susceptibility to protein aggregation diseases.

Future Directions

Proposed studies for Tapirus indicus CRYAA:

  1. Cloning and Expression: Use yeast or mammalian systems to produce His-tagged recombinant protein .

  2. Functional Assays: Compare chaperone activity with human/mouse CRYAA using βL-crystallin or insulin aggregation models .

  3. Structural Analysis: Cryo-EM or NMR to resolve oligomeric states and domain interactions .

Product Specs

Form
Lyophilized powder. We will ship the format in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery time varies by purchase method and location. Consult your local distributor for specifics. All proteins ship with blue ice packs. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
CRYAA; Alpha-crystallin A chain
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-173
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Tapirus indicus (Asiatic tapir) (Malayan tapir)
Target Names
CRYAA
Target Protein Sequence
MDIAIQHPWF KRTLGPFYPS RLFDQFFGEG LFEYDLLPFL SSTISPYYRQ SLFRTVLDSG ISEVRSDRDK FVIFLDVKHF SPEDLTVKVQ EDFVEIHGKH NERQDDHGYI SREFHRRYRL PSNVDQTALS CSLSADGMLT FSGPKVPSGL DAGHSERAIP VSREEKPSSA PSS
Uniprot No.

Target Background

Function
Contributes to lens transparency and refractive index. Acts as a chaperone, preventing protein aggregation under stress. Required for correct lens intermediate filament formation as part of a BFSP1, BFSP2, and CRYAA complex.
Protein Families
Small heat shock protein (HSP20) family
Subcellular Location
Cytoplasm. Nucleus.

Q&A

What is Alpha-crystallin A chain (CRYAA) and its significance in Tapirus indicus?

Alpha-crystallin A chain (CRYAA) is a member of the small heat-shock protein (sHSP) family that functions as a molecular chaperone and exhibits anti-apoptotic properties. In the context of Tapirus indicus (Malayan tapir), CRYAA represents an important protein for both conservation genetics and fundamental biochemical research. The Malayan tapir has been listed as 'endangered' since 2008, with fewer than 2,500 mature individuals in the wild and approximately 150 in captivity. Genetic studies of proteins like CRYAA provide valuable insights into the species' genetic diversity, which is crucial for conservation efforts. Understanding the structure and function of CRYAA in this endangered species contributes to both conservation genetics and comparative biochemistry across mammalian species .

How do researchers isolate and express recombinant CRYAA from Tapirus indicus?

Isolation and expression of recombinant CRYAA from Tapirus indicus typically follows a multi-stage process. Researchers first extract genomic DNA from tissue samples collected from Malayan tapirs, often from captive individuals in conservation programs. The CRYAA gene is then amplified using PCR with primers designed based on conserved regions of the CRYAA gene across related species. The amplified gene is cloned into an appropriate expression vector (commonly pET or pGEX systems) containing an N-terminal tag such as GST for purification purposes. The recombinant plasmid is transformed into E. coli expression hosts (typically BL21 strains), and protein expression is induced using IPTG under optimized conditions. The recombinant protein is then purified using affinity chromatography, with the active full-length CRYAA protein corresponding to amino acids 1-173. Protein purity and activity are verified through SDS-PAGE, Western blotting, and functional assays to ensure the recombinant protein maintains its chaperone activity .

What is known about the genetic diversity of CRYAA in wild Tapirus indicus populations?

Analysis of the genetic diversity of CRYAA across wild Tapirus indicus populations has revealed significant variation related to geographical distribution. Studies examining nucleotide diversity in Malayan tapir populations found that specimens from Peninsular Malaysia showed almost double the nucleotide diversity (0.00703) compared to Thailand populations (0.00362), despite similar haplotype diversity (0.855-0.877). Genetic assessment identified 38 variable sites and 23 distinct haplotypes organized into two main clades that diverged approximately 1.46 million years ago (Mya). This genetic variation appears to correspond with geographical isolation and has important implications for conservation. The higher genetic diversity in Peninsular Malaysia suggests this region may serve as an important reservoir of genetic variation for the species, while the presence of distinct lineages indicates the importance of managing populations as separate conservation units to preserve genetic diversity .

What protein-protein interactions have been identified for CRYAA and what do they reveal about its function?

Human proteome (HuProt) microarray studies have revealed an extensive network of CRYAA interactions, identifying 343 proteins with higher signals in recombinant CRYAA groups compared to controls. Of these, 127 proteins showed significant interaction (signal-to-noise ratio ≥ 1.2). Eight proteins demonstrated particularly strong interactions (SNR > 3.0): hematopoietic cell-specific Lyn substrate 1 (HCLS1), Kelch domain-containing 6 (KLHDC6), sarcoglycan delta (SGCD), KIAA1706 protein, RNA guanylyltransferase and 5′-phosphatase (RNGTT), chromosome 10 open reading frame 57 (C10orf57), chromosome 9 open reading frame 52 (C9orf52), and plasminogen activator, urokinase receptor (PLAUR).

Functional clustering analysis revealed three primary groups of interacting proteins that contribute to CRYAA's protective role against oxidative damage:

  • DNA metabolism and repair proteins - Including RAD51, PTTG2, PMS2, and EYA4, which are essential for cell proliferation and responses to DNA damage

  • Antiapoptotic regulatory proteins - Functioning through multiple pathways to prevent cell death

  • Stress response proteins - Related to cellular protection mechanisms

These interactions suggest that CRYAA's chaperone function extends beyond preventing protein aggregation to include significant roles in DNA repair, cellular stress response, and apoptosis regulation, making it a multifunctional protein involved in cellular protection mechanisms .

How do the chaperone peptides of CRYAA function in preventing protein aggregation and apoptosis?

The chaperone function of CRYAA is mediated by specific peptide sequences that have been identified as "mini-chaperones." Studies have identified the peptide (70)KFVIFLDVKHFSPEDLTVK(88) in αA-crystallin as one such mini-chaperone. This peptide exhibits chaperone activity similar to the full-length protein but can penetrate cells more efficiently due to its smaller size.

Mechanistically, these mini-chaperones function through:

  • Prevention of protein aggregation: The peptides bind to partially unfolded proteins, preventing their aggregation during stress conditions. This has been demonstrated through stress-induced aggregation assays with four different client proteins, where CRYAA peptides effectively inhibited aggregation.

  • Inhibition of apoptotic pathways: CRYAA mini-chaperones directly inhibit apoptosis by:

    • Preventing cytochrome c release from mitochondria

    • Inhibiting caspase-3 and caspase-9 activation

    • Maintaining mitochondrial membrane potential

  • Post-translational modifications: Acetylation of lysine 70 (Lys70) enhances the chaperone activity of the peptide, with acetylated peptides showing greater effectiveness against three client proteins compared to unmodified peptides.

In experimental models of cataract, these peptides demonstrated significant protective effects by inhibiting oxidative stress, protein insolubilization, and caspase activity, indicating their potential therapeutic applications in treating conditions involving protein aggregation and apoptosis .

What methodological approaches are most effective for studying recombinant CRYAA interactions with other proteins?

Several complementary methodological approaches have proven effective for studying recombinant CRYAA interactions:

  • Human Proteome (HuProt) Microarray: This high-throughput approach allows screening of over 17,000 human full-length proteins simultaneously. Recombinant CRYAA with appropriate tags is incubated on the array, followed by detection using fluorescently labeled antibodies. Signal-to-noise ratio (SNR) analysis is used to identify significant interactions, with an SNR ≥ 1.2 typically considered significant. This technique provides a comprehensive overview of potential protein interactions.

  • Co-immunoprecipitation (Co-IP): For validation of specific interactions identified through microarray screening. Recombinant CRYAA with affinity tags (GST or His) is incubated with cellular lysates, followed by pull-down and identification of interacting partners by mass spectrometry or Western blotting.

  • Yeast Two-Hybrid (Y2H) Analysis: Particularly useful for detecting direct protein-protein interactions. The CRYAA coding sequence is cloned into bait vectors, and potential interacting proteins into prey vectors, allowing in vivo detection of interactions through reporter gene activation.

  • Surface Plasmon Resonance (SPR): For quantitative analysis of binding kinetics between CRYAA and identified partner proteins, providing association and dissociation constants that characterize interaction strength.

  • Bioinformatics Analysis: Tools such as the DAVID database are essential for functional clustering of identified interacting proteins, revealing biological pathways and functional networks associated with CRYAA .

How does CRYAA contribute to the conservation genetics of Tapirus indicus?

CRYAA serves as an important genetic marker for conservation genetics of Tapirus indicus in several key ways:

  • Population Genetic Structure Assessment: Analysis of CRYAA sequence variants has helped identify distinct genetic lineages within the global Tapirus indicus population. Genetic assessment has revealed two main clades that diverged approximately 1.46 million years ago, providing insights into the evolutionary history and population structure of this endangered species.

  • Effective Population Size Estimation: CRYAA genetic data has contributed to the estimation of historical effective population size (Ne) of Malayan tapir populations. Using single nucleotide polymorphism (SNP) variants and sequentially Markovian coalescent-based inference frameworks, researchers have traced population dynamics from the Early Pleistocene (approximately 1 million years ago) to as recently as 10,000 years ago.

  • Management of Captive Populations: Genetic information derived from CRYAA studies helps inform breeding programs for captive Malayan tapirs. By understanding genetic relationships between individuals, conservation managers can:

    • Prevent inbreeding

    • Maintain genetic diversity

    • Make informed decisions about population management

  • Conservation Strategy Development: CRYAA genetic data supports specific conservation recommendations, including:

    • Evaluation and improvement of forest linkages in Peninsular Malaysia to prevent inbreeding of isolated populations

    • Management of captive and wild populations using genetic diversity indices and effective population size estimates

    • Introduction of captive-bred individuals into genetically related wild populations

    • Limiting interbreeding between individuals from Sumatran and mainland Southeast Asian populations until effects on functional genes can be determined .

What experimental designs are most effective for studying the anti-apoptotic properties of CRYAA?

Research on CRYAA's anti-apoptotic properties employs several experimental approaches, each offering unique insights:

  • Cell Culture Models:

    • Mammalian cell lines exposed to apoptosis-inducing stresses (oxidative stress, heat shock, UV radiation)

    • Measurement of cell viability using MTT/XTT assays or flow cytometry with Annexin V/PI staining

    • Transfection with CRYAA expression constructs or treatment with recombinant CRYAA/mini-chaperone peptides

    • Analysis of apoptotic markers including cytochrome c release, caspase-3/9 activation, and PARP cleavage

  • Organ Culture Systems:

    • Rat lens epithelial cell cultures treated with apoptosis inducers like calcimycin

    • Assessment of epithelial cell apoptosis through TUNEL assays and immunohistochemistry

    • Treatment with CRYAA peptides at various concentrations to establish dose-response relationships

  • In Vivo Models:

    • Selenite-induced cataract in rat models

    • Intraperitoneal injection of CRYAA peptides (both native and acetylated forms)

    • Measurement of oxidative stress markers (lipid peroxidation, protein carbonylation)

    • Assessment of protein insolubilization and aggregation

    • Quantification of caspase activity in lens tissue

  • Comparative Analysis:

    • Side-by-side comparison of native versus acetylated CRYAA peptides

    • Inclusion of scrambled peptide controls to confirm sequence-specific effects

    • Dose-response studies to determine optimal concentrations for anti-apoptotic effects

These experimental designs have demonstrated that CRYAA peptides inhibit stress-induced apoptosis by preventing cytochrome c release from mitochondria and inhibiting caspase activation, with acetylated peptides showing enhanced protective effects compared to native peptides .

Key Protein Interactions with CRYAA Identified by HuProt Microarray

ProteinFull NameSNR ValueFunction
HCLS1Hematopoietic cell-specific Lyn substrate 1>3.0Cell signaling and cytoskeletal regulation
KLHDC6Kelch domain-containing 6>3.0Protein-protein interactions
SGCDSarcoglycan delta>3.0Structural protein in muscle cells
KIAA1706KIAA1706 protein>3.0Uncharacterized function
RNGTTRNA guanylyltransferase and 5′-phosphatase>3.0RNA processing
C10orf57Chromosome 10 open reading frame 57>3.0Unknown function
C9orf52Chromosome 9 open reading frame 52>3.0Unknown function
PLAURPlasminogen activator, urokinase receptor>3.0Cell surface receptor involved in localized degradation of ECM

This table presents the eight proteins showing strongest interactions with CRYAA (SNR >3.0) as identified through HuProt microarray analysis. Beyond these, an additional 119 proteins showed significant interactions (SNR ≥1.2), while a total of 343 proteins showed higher signals in the CRYAA group than in controls .

Comparison of Genetic Diversity in Tapirus indicus Populations

PopulationNucleotide DiversityHaplotype DiversityNumber of Haplotypes
Peninsular Malaysia0.007030.855-0.877Not specified
Thailand0.003620.855-0.877Not specified
Total (SEA)Not specifiedNot specified23

Genetic analysis has identified two main clades that diverged approximately 1.46 million years ago (Mya), comprising a total of 23 haplotypes across Southeast Asian populations. The nucleotide diversity in Peninsular Malaysia was almost double that of Thailand, despite similar haplotype diversity values .

Functional Effects of CRYAA Mini-Chaperone Peptides

PropertyNative αA PeptideAcetylated αA PeptideScrambled Peptide
Protein Aggregation InhibitionEffectiveMore effective than nativeNo effect
Stress-induced Apoptosis InhibitionEffectiveMore effective than nativeNo effect
Cytochrome c Release PreventionYesEnhanced effectNo
Caspase-3/9 InhibitionYesEnhanced effectNo
In vivo Cataract PreventionEffectiveMore effective than nativeNo effect
Oxidative Stress InhibitionYesEnhanced effectNo
Protein Insolubilization PreventionYesEnhanced effectNo

The table demonstrates that both native and acetylated αA-crystallin mini-chaperone peptides effectively inhibit protein aggregation and apoptosis, with acetylated peptides showing enhanced efficacy. The peptide sequence (70)KFVIFLDVKHFSPEDLTVK(88) in αA-crystallin is critical for these functions, as scrambled peptides showed no protective effects .

What are the most promising areas for future research on Tapirus indicus CRYAA?

Several promising research directions emerge from current understanding of Tapirus indicus CRYAA:

  • Comparative Genomics: Further sequencing of the CRYAA gene across the remaining wild populations could reveal additional genetic variations and help refine conservation strategies. Using whole genome sequencing techniques and comparing CRYAA genes between isolated populations would provide deeper insights into evolutionary adaptations and population structure.

  • Functional Genomics: Investigating the specific functions of CRYAA variants identified in different Tapirus indicus populations. This includes examining how population-specific mutations might affect protein structure, chaperone activity, and anti-apoptotic properties through recombinant protein expression and activity assays.

  • Conservation Applications: Developing CRYAA-based genetic markers for non-invasive monitoring of wild Tapirus indicus populations. This could include designing PCR primers for fecal DNA analysis or environmental DNA (eDNA) detection methods based on CRYAA sequence variations.

  • Therapeutic Applications: Exploring the potential therapeutic applications of Tapirus indicus CRYAA peptides, particularly the mini-chaperone regions, for treating human conditions involving protein aggregation and oxidative stress. Cross-species comparison of anti-apoptotic efficacy could reveal evolutionary adaptations with therapeutic potential .

How might genomic approaches enhance our understanding of CRYAA function in Tapirus indicus?

Advanced genomic approaches offer powerful tools for understanding CRYAA function in Tapirus indicus:

  • Whole Genome Sequencing and Analysis: Sequencing the genomes of multiple Tapirus indicus individuals from different populations (Thailand, Malaysia, and Sumatra) can provide a comprehensive view of genetic variation in CRYAA and related genes. This approach has already begun with six Malayan tapirs whose genomes were sequenced using next-generation sequencing technology.

  • Sequentially Markovian Coalescent Analysis: This computational approach uses genomic data to estimate historical effective population size (Ne) and population split times. For Tapirus indicus, this has provided insights into population dynamics from early Pleistocene (approximately 1 Mya) to recent history (10 kya).

  • Transcriptomics: RNA-seq analysis of Tapirus indicus tissues could reveal expression patterns of CRYAA across different tissues and developmental stages, providing insights into its broader biological roles beyond lens tissue.

  • Epigenetic Studies: Investigating methylation patterns and histone modifications of the CRYAA gene in different Tapirus indicus populations could reveal environmental adaptations and regulatory mechanisms affecting protein function.

  • CRISPR-Cas9 Gene Editing: While ethically limited in endangered species, cell culture models could be developed using tapir cells with CRISPR-modified CRYAA genes to study the functional consequences of specific mutations identified in wild populations.

These genomic approaches can enhance conservation genetics by providing deeper insights into population structure, evolutionary history, and functional adaptations of CRYAA in this endangered species .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.